Peptide cocktail ovarian cancer vaccine (Iwate Medical University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeptide cocktail ovarian cancer vaccine (Iwate Medical University)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIwate Medical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIwate Medical University
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A